by Prakash Achaary | Aug 16, 2022 | Blog
Natural language processing (NLP) is a powerful tool revolutionizing how information is collected, stored and used in healthcare and health science. Due to the complexity of data in a healthcare setting, natural language processing is a particularly useful data...
by Prakash Achaary | Jul 29, 2022 | Blog
As regulations around clinical trial data disclosure continue to increase in complexity, it can be difficult to keep up with the changes. We asked Raina Agarwal, Associate Director of Clinical Trial Disclosure, to give us a class in Clinical Trials 101 to go over the...
by Prakash Achaary | Jun 28, 2022 | News
The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS’ leadership in data-focused clinical research services. CANTON, Michigan – June 28, 2022 – MMS Holdings Inc. (“MMS” or the “Company”), a leading data-focused...
by Prakash Achaary | Jun 27, 2022 | News
On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted...
by Prakash Achaary | Jun 22, 2022 | Blog
I attended the American Chemical Society (ACS) Central Regional Meeting – CERM 2022 in person, hosted at Eastern Michigan University in Ypsilanti, Michigan, June 7-10th Attendance was still adversely affected by understandable caution around COVID-19 and flight...